Eric Lefebvre, Chief Medical Officer at PLIANT THERAPEUTICS, INC. (PLRX), sold 16,228 shares at $28.62 ($471K) on 2021-06-18, disclosed to the SEC on 2021-06-22.
Open-market sale of $471k PLRX by Chief Medical Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $28.62 | 8,750 | $250K | 53.2% |
| 2 | $29.43 | 3,728 | $110K | 23.3% |
| 3 | $29.43 | 3,728 | $110K | 23.3% |
| 4 | $30.23 | 22 | $665 | 0.1% |
| Total | $28.99 avg | 16,228 | $471K | 100% |
| Filing → |
| PLRX | SELL | 2024-01-19 | $355K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $804K | — | Filing → |
| PLRX | SELL | 2023-04-03 | $596K | — | Filing → |